RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
published in: Nature Medicine
date of publication: 2022-09-12
Cites articles
There is nothing here
Article - wd:Q114109173
There is nothing here
Article - wd:Q114109173